CoChat

Short-term administration of Nicotinamide Mononucleotide preserves cardiac mitochondrial homeostasis and prevents heart failure

Open access
Zhang, Rongli, Shen, Yuyan, Zhou, Lin, Sangwung, Panjamaporn, Fujioka, Hisashi, Zhang, Lilei, Liao, Xudong · 2017 · Journal of Molecular and Cellular Cardiology
Cited by 78

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

Heart failure is associated with mitochondrial dysfunction so that restoring or improving mitochondrial health is of therapeutic importance. Recently, reduction in NAD+ levels and NAD+-mediated deacetylase activity has been recognized as negative regulators of mitochondrial function. Using a cardiac specific KLF4 deficient mouse line that is sensitive to stress, we found mitochondrial protein hyperacetylation coupled with reduced Sirt3 and NAD+ levels in the heart before stress, suggesting that the KLF4-deficient heart is predisposed to NAD+-associated defects. Further, we demonstrated that short-term administration of Nicotinamide Mononucleotide (NMN) successfully protected the mutant mice from pressure overload-induced heart failure. Mechanically, we showed that NMN preserved mitochondrial ultrastructure, reduced ROS and prevented cell death in the heart. In cultured cardiomyocytes, NMN treatment significantly increased long-chain fatty acid oxidation despite no direct effect on pyruvate oxidation. Collectively, these results provide cogent evidence that hyperacetylation of mitochondrial proteins is critical in the pathogenesis of cardiac disease and that administration of NMN may serve as a promising therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.yjmcc.2017.09.001

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Research works printed but not linked: 30

  1. Lopaschuk, 2010, Myocardial fatty acid metabolism in health and disease, Physiol. Rev., 90, 207, 10.1152/physrev.00015.2009 · DOI · Paper page
  2. Huss, 2005, Mitochondrial energy metabolism in heart failure: a question of balance, J. Clin. Invest., 115, 547, 10.1172/JCI24405 · doi:10.1172/jci24405 · Paper page
  3. Riehle, 2012, PGC-1 proteins and heart failure, Trends Cardiovasc. Med., 22, 98, 10.1016/j.tcm.2012.07.003 · DOI
  4. Schilling, 2011, The PGC-1 cascade as a therapeutic target for heart failure, J. Mol. Cell. Cardiol., 51, 578, 10.1016/j.yjmcc.2010.09.021 · DOI
  5. Aubert, 2013, Perturbations in the gene regulatory pathways controlling mitochondrial energy production in the failing heart, Biochim. Biophys. Acta (BBA), 1833, 840, 10.1016/j.bbamcr.2012.08.015 · DOI
  6. den Boer, 2003, Mitochondrial trifunctional protein deficiency: a severe fatty acid oxidation disorder with cardiac and neurologic involvement, J. Pediatr., 142, 684, 10.1067/mpd.2003.231 · DOI
  7. Hock, 2009, Transcriptional control of mitochondrial biogenesis and function, Annu. Rev. Physiol., 71, 177, 10.1146/annurev.physiol.010908.163119 · DOI · Paper page
  8. Heggermont, 2016, Metabolic support for the heart: complementary therapy for heart failure?, Eur. J. Heart Fail., 18, 1420, 10.1002/ejhf.678 · DOI
  9. Neubauer, 2007, The failing heart--an engine out of fuel, N. Engl. J. Med., 356, 1140, 10.1056/NEJMra063052 · DOI · Paper page
  10. Lesnefsky, 2001, Mitochondrial dysfunction in cardiac disease: ischemia--reperfusion, aging, and heart failure, J. Mol. Cell. Cardiol., 33, 1065, 10.1006/jmcc.2001.1378 · DOI · Paper page
  11. Lee, 2016, Normalization of NAD+ redox balance as a therapy for heart failure, Circulation, 134, 883, 10.1161/CIRCULATIONAHA.116.022495 · DOI · Paper page
  12. Kris-Etherton, 2004, Nutrition Committee of the American Heart Association Council on nutrition, metabolism, antioxidant vitamin supplements and cardiovascular disease, Circulation, 110, 637, 10.1161/01.CIR.0000137822.39831.F1 · DOI · Paper page
  13. Yang, 2016, Mitochondrial sirtuin network reveals dynamic sirt3-dependent deacetylation in response to membrane depolarization, Cell, 167, 985, 10.1016/j.cell.2016.10.016 · DOI · Paper page
  14. Atkins, 2007, Role of Kruppel-like transcription factors in endothelial biology, Circ. Res., 100, 1686, 10.1161/01.RES.0000267856.00713.0a · DOI · Paper page
  15. Haldar, 2007, Kruppel-like Factors (KLFs) in muscle biology, J. Mol. Cell. Cardiol., 43, 1, 10.1016/j.yjmcc.2007.04.005 · DOI
  16. McConnell, 2010, Mammalian Kruppel-like factors in health and diseases, Physiol. Rev., 90, 1337, 10.1152/physrev.00058.2009 · DOI · Paper page
  17. Liao, 2010, Kruppel-like factor 4 regulates pressure-induced cardiac hypertrophy, J. Mol. Cell. Cardiol., 49, 334, 10.1016/j.yjmcc.2010.04.008 · DOI · Paper page
  18. Haldar, 2010, Klf15 deficiency is a molecular link between heart failure and aortic aneurysm formation, Sci. Transl. Med., 2, 26ra26, 10.1126/scitranslmed.3000502 · DOI · Paper page
  19. Liao, 2015, Kruppel-like factor 4 is critical for transcriptional control of cardiac mitochondrial homeostasis, J. Clin. Invest., 125, 3461, 10.1172/JCI79964 · DOI · Paper page
  20. Dikalova, 2017, Sirt3 impairment and SOD2 hyperacetylation in vascular oxidative stress and hypertension, Circ. Res., 121, 564, 10.1161/CIRCRESAHA.117.310933 · DOI · Paper page
  21. Bharathi, 2013, Sirtuin 3 (SIRT3) protein regulates long-chain acyl-CoA dehydrogenase by deacetylating conserved lysines near the active site, J. Biol. Chem., 288, 33837, 10.1074/jbc.M113.510354 · DOI · Paper page
  22. Hershberger, 2017, Role of NAD+ and mitochondrial sirtuins in cardiac and renal diseases, Nat. Rev. Nephrol., 13, 213, 10.1038/nrneph.2017.5 · DOI · Paper page
  23. Rosca, 2008, Cardiac mitochondria in heart failure: decrease in respirasomes and oxidative phosphorylation, Cardiovasc. Res., 80, 30, 10.1093/cvr/cvn184 · DOI · Paper page
  24. Horton, 2016, Mitochondrial protein hyperacetylation in the failing heart, JCI Insight, 2
  25. Dittenhafer-Reed, 2015, SIRT3 mediates multi-tissue coupling for metabolic fuel switching, Cell Metab., 21, 637, 10.1016/j.cmet.2015.03.007 · DOI · Paper page
  26. Yu, 2012, SIRT3 protein deacetylates isocitrate dehydrogenase 2 (IDH2) and regulates mitochondrial redox status, J. Biol. Chem., 287, 14078, 10.1074/jbc.M112.355206 · DOI · Paper page
  27. Alrob, 2014, Obesity-induced lysine acetylation increases cardiac fatty acid oxidation and impairs insulin signalling, Cardiovasc. Res., 103, 485, 10.1093/cvr/cvu156 · DOI · Paper page
  28. Fukushima, 2016, Acetylation control of cardiac fatty acid beta-oxidation and energy metabolism in obesity, diabetes, and heart failure, Biochim. Biophys. Acta, 1862, 2211, 10.1016/j.bbadis.2016.07.020 · DOI
  29. Bernardi, 2015, The mitochondrial permeability transition pore: molecular nature and role as a target in cardioprotection, J. Mol. Cell. Cardiol., 78, 100, 10.1016/j.yjmcc.2014.09.023 · DOI · Paper page
  30. Giordano, 2005, Oxygen, oxidative stress, hypoxia, and heart failure, J. Clin. Invest., 115, 500, 10.1172/JCI200524408 · DOI · Paper page

Cited by

See all 78

Metadata

Authors
Zhang, R., Shen, Y., Zhou, L., Sangwung, P., Fujioka, H., Zhang, L., & Liao, X.
Venue
Journal of Molecular and Cellular Cardiology
Publisher
Elsevier BV
Published
2017-11
Volume
112
Pages
64-73
ISSN
0022-2828 (ISSN-L)
OpenAlex
W2751396798
Cited by
78
References
15
FWCI
2.87
Type
journal article
Language
en
Open access
green
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Short-term administration of Nicotinamide Mononucleotide preserves cardiac mitochondrial homeostasis and prevents heart failure. https://app.cochat.ai/papers/10.1016/j.yjmcc.2017.09.001
The paper
Zhang, R., Shen, Y., Zhou, L., Sangwung, P., Fujioka, H., Zhang, L., & Liao, X. (2017). Short-term administration of Nicotinamide Mononucleotide preserves cardiac mitochondrial homeostasis and prevents heart failure. Journal of Molecular and Cellular Cardiology. https://doi.org/10.1016/j.yjmcc.2017.09.001

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.